BIA
IMGN

Bell Investment Advisors’s Immunogen Inc IMGN Stock Holding History

Bell Investment Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-62
Closed -$1.84K – 1959
2023
Q4 		$1.84K Buy
62
+36
+138% +$717 ﹤0.01% 1360
2023
Q3 		$413 Sell
26
-9
-26% -$150 ﹤0.01% 1858
2023
Q2 		$661 Buy
+35
New +$413 ﹤0.01% 1712

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bell Investment Advisors's IMGN Position: Q1 2024 in Review

Bell Investment Advisors sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 62 shares — an estimated $1.84K sold.

Bell Investment Advisors first reported a position in IMGN in Q2 2023 and held it in 3 quarters. The position peaked at $1.84K in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Bell Investment Advisors reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Bell Investment Advisors sold 62 Immunogen Inc shares in Q1 2024, an estimated $1.84K.
  • Bell Investment Advisors first reported a position in Immunogen Inc in Q2 2023 and held it in 3 quarters.
  • Bell Investment Advisors's Immunogen Inc position peaked at $1.84K in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Bell Investment Advisors's 13F filing for Q1 2024, filed 8 May 2024.